vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and QUINSTREET, INC (QNST). Click either name above to swap in a different company.
QUINSTREET, INC is the larger business by last-quarter revenue ($287.8M vs $207.8M, roughly 1.4× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 17.4%, a 39.9% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $20.7M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
QUINSTREET, INCQNSTEarnings & Financial Report
QuinStreet, Inc. is a publicly traded online marketing company based in Foster City, California. The company helps generate web traffic for clients by acquiring popular domain names.
IDYA vs QNST — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $287.8M |
| Net Profit | $119.2M | $50.2M |
| Gross Margin | — | 9.6% |
| Operating Margin | 52.2% | 0.4% |
| Net Margin | 57.4% | 17.4% |
| Revenue YoY | — | 1.9% |
| Net Profit YoY | 330.1% | 3342.5% |
| EPS (diluted) | $1.33 | $0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $287.8M | ||
| Q3 25 | $207.8M | $285.9M | ||
| Q1 25 | — | $269.8M | ||
| Q4 24 | — | $282.6M | ||
| Q3 24 | $0 | $279.2M | ||
| Q2 24 | $0 | $198.3M | ||
| Q1 24 | $0 | $168.6M | ||
| Q4 23 | — | $122.7M |
| Q4 25 | — | $50.2M | ||
| Q3 25 | $119.2M | $4.5M | ||
| Q1 25 | — | $4.4M | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | $-51.8M | $-1.4M | ||
| Q2 24 | $-52.8M | $-2.2M | ||
| Q1 24 | $-39.6M | $-7.0M | ||
| Q4 23 | — | $-11.6M |
| Q4 25 | — | 9.6% | ||
| Q3 25 | — | 9.4% | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | — | 9.5% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.8% | ||
| Q1 24 | — | 8.5% | ||
| Q4 23 | — | 5.6% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | 52.2% | 1.7% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | -0.5% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | -0.7% | ||
| Q1 24 | — | -3.2% | ||
| Q4 23 | — | -9.3% |
| Q4 25 | — | 17.4% | ||
| Q3 25 | 57.4% | 1.6% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | -0.5% | ||
| Q3 24 | — | -0.5% | ||
| Q2 24 | — | -1.1% | ||
| Q1 24 | — | -4.2% | ||
| Q4 23 | — | -9.4% |
| Q4 25 | — | $0.87 | ||
| Q3 25 | $1.33 | $0.08 | ||
| Q1 25 | — | $0.08 | ||
| Q4 24 | — | $-0.03 | ||
| Q3 24 | $-0.60 | $-0.02 | ||
| Q2 24 | $-0.68 | $-0.04 | ||
| Q1 24 | $-0.53 | $-0.13 | ||
| Q4 23 | — | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $107.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $294.4M |
| Total Assets | $1.2B | $493.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $107.0M | ||
| Q3 25 | $786.9M | $101.3M | ||
| Q1 25 | — | $81.8M | ||
| Q4 24 | — | $57.8M | ||
| Q3 24 | $920.0M | $25.0M | ||
| Q2 24 | $701.7M | $50.5M | ||
| Q1 24 | $698.8M | $39.6M | ||
| Q4 23 | — | $45.5M |
| Q4 25 | — | $294.4M | ||
| Q3 25 | $1.1B | $246.7M | ||
| Q1 25 | — | $235.5M | ||
| Q4 24 | — | $224.3M | ||
| Q3 24 | $1.2B | $219.8M | ||
| Q2 24 | $931.7M | $216.8M | ||
| Q1 24 | $935.3M | $215.0M | ||
| Q4 23 | — | $215.3M |
| Q4 25 | — | $493.0M | ||
| Q3 25 | $1.2B | $442.6M | ||
| Q1 25 | — | $417.2M | ||
| Q4 24 | — | $409.6M | ||
| Q3 24 | $1.2B | $401.2M | ||
| Q2 24 | $973.7M | $368.5M | ||
| Q1 24 | $961.5M | $349.3M | ||
| Q4 23 | — | $320.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $21.6M |
| Free Cash FlowOCF − Capex | $142.2M | $20.7M |
| FCF MarginFCF / Revenue | 68.4% | 7.2% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | 1.19× | 0.43× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $106.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $21.6M | ||
| Q3 25 | $142.2M | $19.6M | ||
| Q1 25 | — | $30.1M | ||
| Q4 24 | — | $38.7M | ||
| Q3 24 | $-49.2M | $-13.7M | ||
| Q2 24 | $-32.9M | $16.6M | ||
| Q1 24 | $-43.8M | $4.1M | ||
| Q4 23 | — | $-3.7M |
| Q4 25 | — | $20.7M | ||
| Q3 25 | $142.2M | $18.4M | ||
| Q1 25 | — | $29.5M | ||
| Q4 24 | — | $38.2M | ||
| Q3 24 | $-49.7M | $-14.1M | ||
| Q2 24 | $-33.9M | $15.4M | ||
| Q1 24 | $-45.1M | $2.9M | ||
| Q4 23 | — | $-5.0M |
| Q4 25 | — | 7.2% | ||
| Q3 25 | 68.4% | 6.4% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | — | 13.5% | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | 7.8% | ||
| Q1 24 | — | 1.7% | ||
| Q4 23 | — | -4.1% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | 0.0% | 0.4% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 0.7% | ||
| Q4 23 | — | 1.1% |
| Q4 25 | — | 0.43× | ||
| Q3 25 | 1.19× | 4.32× | ||
| Q1 25 | — | 6.82× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
QNST
| Financial Service | $216.8M | 75% |
| Home Services And Other Revenue | $71.0M | 25% |
